Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...
People with type 2 diabetes are usually told to have regular eye checks to protect their vision. These tests look for damage caused by high blood sugar, which can harm the tiny blood vessels in the ...
November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
Hosted on MSN
From fatigue to blurry vision: These health problems may be early signs indicating diabetes
You may find yourself experiencing small changes in your health that seem easy to dismiss, yet these early discomforts often carry a deeper message about what is happening inside your body. Diabetes ...
Please provide your email address to receive an email when new articles are posted on . The odds of developing dry eye disease were nearly four-times higher in patients with moderate to severe ...
Share on Pinterest New research links GLP-1 medications such as semaglutide and tirzepatide to a doubled risk of potentially blinding eye diseases. Javier Zayas Photography/Getty Images The most ...
Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results